Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD in Europe
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, reposted from EAHAD on LinkedIn:
”Understanding access to diagnostic tools and treatment options for von Willebrand disease across Europe is essential to improving care and identifying unmet needs.
I encourage all healthcare professionals involved in the diagnosis and treatment of VWD across Europe to take a few minutes to participate in this survey and share their experience.
Your input will help provide a clearer picture of current practice and resource availability across different clinical settings.”
Quoting European Association for Haemophilia and Allied Disorders (EAHAD)‘s post:
”The EAHAD von Willebrand Disease (VWD) Working Group has launched a new survey to assess the availability of diagnostic tools and treatment options across European medical centers.
The aim is to better understand current clinical practice, available resources, and real-world access to care across different settings.
We invite healthcare professionals to contribute their experience and insights.
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026